Connection

Mark Rubinstein to Ipilimumab

Back to Details
This is a "connection" page, showing publications Mark Rubinstein has written about Ipilimumab.
Mark Rubinstein
Connection Strength
0.042
Ipilimumab
  1. Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Ra Complexes Enhances Tumor Control. Cancer Immunol Res. 2019 08; 7(8):1371-1380.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.